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copies/ sample, and the whole procedure from DNA extraction to
analysis requires less than 2 hours. The positive sample can be
further quantitated by using real time PCR. We also developed real
time PCR system to measure copy number of HAV, HEV, GBV,
Adenovirus, Norovirus, Metapneumovirus, Pn. jirovecci, Toxo-
plasma, and Cryptosporidium. Analysis of 980 samples from 145
patients who underwent SCT revealed that 18% of blood/urine
samples were positive for more than one virus. Although infections
with multiple viruses were less frequent in CBT-recipient than
allogeneic BMT/PBSCT-recipients, most of the CBT-recipients
with coinfection/superinfection showed profound immunodeﬁ-
ciency. Serious virus infection such as ganciclovir-resistant CMV
infection was noted in 9 out of 40 CBT-recipients. Opportunistic
infections in CBT stem from secondary immunodeﬁciency, which
often leads to predisposition to other infections, and to indirect
consequences such as graft rejection and leukemic relapse. Mea-
sures to facilitate rapid immune reconstitution would result in
control of ongoing infection and reduce non-relapse mortality.
Donor lymphocyte infusion (DLI), although not available in CBT-
recipients, would potentially be effective for opportunistic infec-
tions. We have developed a simple method for expanding activated
donor CD4-T cells from cord blood mononuclear cells (MNCs).
CD4 T-cell function such as cytokine production, was comparable
to those of adult expanded CD4 T-cells. Infusion of CD4 T-cells
expanded from cord blood was effective for viral infections such as
drug-resistant CMV disease and Coxsackie B hemorrhagic colitis.
Aggravation of GVHD, cytopenia, or organ damage was not noted
in CD4-DLI for these patients. Preparation of expanded CD4
T-cells from engrafted MNCs with low CD4 T-cells is sometimes
challenging. We would need to decide whether CD4 T-cells
should be expanded for high risk patients or for all the recipients in
advance. CD4-DLI would serve as “the second generation DLI” in
CBT since it needs small amount of blood; stimulates various limbs
of immune system; and is associated with minimal side effects.
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STEM CELLS IN THE UMBILICAL CORD MATRIX: ISOLATION AND CHAR-
ACTERIZATION
Mark L. Weiss Kansas State University, Dept of Anatomy and Physi-
ology, Midwest Institute for Comparative Stem Cell Biology, Manhattan,
KS 66506, USA
The umbilical cord is a non-controversial source of mesenchy-
mal-like stem cells (MSCs). Work from several laboratories shows
that MSCs can be isolated from several different compartments of
the umbilical cord including the umbilical cord blood (UCB), the
amnion and amniotic ﬂuid, the perivascular compartment, etc.
Work with cells derived from Wharton’s Jelly that have been
termed umbilical cord matrix (UCM) cells will be described here.
UCM cells are plastic-adherent cells that have similar surface
phenotype, differentiation potential and physiological properties to
MSCs derived from other tissues sources such as bone marrow and
adipose tissue. Unlike MSCs derived from “adult” sources, UCM
cells have several advantages, not the least of which is that they are
collected from a fairly homogenous, young population, minimal
surgical risk to patient, etc. Several labs have demonstrated a
therapeutic potential for the UCM cells in experimental disease
models, indicating the possibly that UCM cells may substitute cell
for bone marrow derived MSCs for cellular therapy, tissue engi-
neering, and biotechnology applications. Our lab and others have
demonstrated that UCM cells have a therapeutic effect in a rodent
model of Parkinson’s disease. Work in other laboratories indicates
that UCM cells may have a rescue function in other degenerative
disease. We envision that both umbilical cord blood and mesen-
chymal cells will be commercially collected and stored in the future
for experimental research and pre-clinical work, for public and
private banking services, etc. While Standard Operating Proce-
dures (SOPs) exist for UCB banking, SOPs are yet to be developed
for clinical-grade UCM cells. Some of hurdles that have been
identiﬁed for the generation of clinical-grade UCM cells will be
discussed.
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MORPHOLOGICAL AND MOLECULAR CHARACTERIZATION OF NOVEL
POPULATION OF CXCR4 SSEA-4 OCT-4 VERY SMALL EMBRYONIC-
LIKE (VSEL) CELLS PURFIED FROM HUMAN CORD BLOOD
Mariusz Z. Ratajczak, Magda Kucia, Maciej Halasa, Marcin Wysoc-
zynski, Bogdan Machalinski Stem Cell Biology Program, James Graham
Brown Cancer Center, University of Louisville, Louisville, KY, USA and
Department of Physiopathology, Pomeranian Medical University, Szc-
zecin, Poland
Mononuclear cells (MNC) isolated from bone marrow (BM) or
cord blood (CB) contributes to organ/tissue regeneration, how-
ever, the identity of the speciﬁc cell type(s) involved remains
unknown. Recently we identiﬁed in murine BM a homogenous
population of rare (0.01% of BMMNC) Sca-1 CXCR4 lin
CD45 cells that express by RQ-PCR and immuno-histochemistry
markers of pluripotent stem cells (PSC) such as SSEA-1, Oct-4,
Nanog and Rex-1, highly express Rif-1 telomerase protein and
display several features typical for primary embryonic stem cells
such as i) a large nuclei surrounded by a narrow rim of cytoplasm,
and iii) open-type chromatin (euchromatin) that is typical for
embryonic stem cells (Leukemia 2006;20,857-869). These cells
(2-4 	m in diameter) were named very small embryonic-like
(VSEL) stem cells. We will present a new two step isolation
procedure to purify a similar population of cells from human CB,
which is based on isolation of CB mononuclear cells (CB MNC) by
hypotonic lysis and multiparameter FACS sorting. Accordingly, we
perform i) hypotonic lysis of CB to remove erythrocytes and to
enrich for CB MNC combined with ii) multiparameter sorting for
CXCR4AC133CD34linCD45 CB MNC. CB-derived
VSEL (CB-VSEL) isolated this way similarly as those isolated
from adult BM are very small (3-5 	m), possess large nuclei
containing unorganized euchromatin, express nuclear embryonic
transcription factors Oct-4 and Nanog and surface embryonic
antigen SSEA-4. VSEL do not express MHC class I and class II
antigens and are CD29, CD90 and CD105 negative. In vitro
cultures CB-VSEL are able to grow neurospheres that gave rise to
neuronal lineages (beta-III tubulin, nestin, O4, MBP,
GFAP) and cardiomyocytes (beta-myosin heavy chain, alpha-
sarcomeric actin. Based on this we conclude that CB contains
VSEL and that the majority of these CB VSEL are lost during
routine procedures employed currently for banking of CB MNC.
Thus based on our observations, new more efﬁcient methods of
CB banking are needed that will enrich/preserve these cells in CB
units during preparation before storage. Furthermore, we conclude
that CB tissue/organ regenerating potential may be much higher
than initially postulated if the proper fraction of CB MNC cells
enriched in VSEL is employed and we are currently testing this
hypothesis in animal models.
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GROWTH OF HIGH PROLIFERATIVE POTENTIAL ENDOTHELIAL COL-
ONY FORMING CELLS FROM UMBILICAL CORD BLOOD
Mervin C. Yoder and David A. Ingram Indiana University School of
Medicine, Indianapolis, IN
Adult peripheral blood has long been known to contain circulat-
ing endothelial cells. Since 1997, umbilical cord blood has been
known to contain a population of circulating cells that serve as
progenitors for the endothelial lineage (EPCs). We have deter-
mined that a rare population of cells in the umbilical cord blood
emerges upon in vitro culture that displays clonal colony forming
ability. These endothelial colony forming cells (ECFCs) are
present in adult peripheral blood as well, though vastly enriched in
term and preterm cord blood. ECFC display a hierarchy of pro-
liferative potential. Cells with the highest proliferative potential
(HPP) can replate into secondary and tertiary high proliferative
potential ECFC, but also give rise to low proliferative potential (do
not self-renew), endothelial clusters, and non-dividing mature en-
dothelial cells. HPP-ECFC display signiﬁcantly greater telomerase
activity than cells with lower proliferative potential. Cord blood
ECFC are capable of forming human vessels when implanted into
1401
